📈 Finance & Markets Daily Briefing
Published: Saturday, November 7, 2026
Here are the most important Finance & Markets stories from the last 24 hours, hand-picked and rated for relevance and impact.
Top Stories
1. Elanco Shares Jump After Q3 Beat and Outlook Raise
Source: bloomberg | Rating: 8.3/10
Elanco Animal Health shares rose nearly 8% after the company reported third-quarter earnings above expectations and raised its full-year outlook. Jeff Simmons, Elanco’s President and CEO, called it a high-quality quarter, citing 11% reported growth and broad strength across markets and product lines. He speaks with Romaine Bostick & Kailey Leinz on "The Close.
💡 Why it matters: AI infrastructure demand is accelerating faster than expected
2. FIGS Beats Earnings as Demand Outstrips Supply, CEO Trina Spear Says
Source: bloomberg | Rating: 8.0/10
FIGS reported third-quarter top- and bottom-line results above expectations, with revenue of $190. 7 million versus an estimate of $182. 8 million. The company logged a fourth consecutive quarter of at least 25% revenue growth; non-scrubwear revenue rose 35%, and international revenue also increased.
💡 Why it matters: Major financial institutions adjusting expectations
3. Sweetgreen CEO Says Sales Rebound After Cyclospora-Related Traffic Drop
Source: bloomberg | Rating: 7.2/10
Sweetgreen CEO and Co-Founder Jonathan Neman says that sales momentum has improved after a summer Cyclospora outbreak—unrelated to Sweetgreen’s stores but damaging to traffic across the sector. The company reported October comparable sales growth of about 5%, following a return to flat comps in September, and saw further improvement in early November. He speaks with Romaine Bostick & Kailey Leinz on "The Close.
💡 Why it matters: Market participants are watching closely
Honorable Mentions
These stories scored between 5.0 and 6.9 — notable, but didn’t crack the top tier.
1. aim immunoTech CEO Equels buys $3,166 in company stock — investing (6.8/10) — Read more
2. Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction — cnbc (6.4/10) — Read more
3. Anthropic IPO announcement odds drop on Kalshi following midterms and AI sell-off — cnbc (6.4/10) — Read more
Delivered by ReDNeK Daily Briefing.
📬 Get tomorrow’s briefing in your inbox
Daily Finance & Markets top stories, hand-picked and ranked. One email, every morning, free.
No spam. Unsubscribe anytime. We never share your email.